Edward White
Stock Analyst at HC Wainwright & Co.
(1.79)
# 3,296
Out of 4,987 analysts
358
Total ratings
29.36%
Success rate
-9.42%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $5.93 | +456.49% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.97 | +70.51% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.66 | +221.89% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.58 | +132.56% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.67 | +858.08% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.56 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $9.00 | +788.89% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.44 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.28 | +777.19% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.37 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $4.08 | +292.16% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.10 | +309.84% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.18 | +577.97% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $11.33 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.76 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $32.04 | +71.66% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $14.75 | +245.76% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.34 | +61.29% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $6.08 | +821.05% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $9.57 | +223.93% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.93 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $7.15 | +9,690.21% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $24.44 | +22.75% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $0.95 | +1,163.16% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $5.93
Upside: +456.49%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.97
Upside: +70.51%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.66
Upside: +221.89%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.58
Upside: +132.56%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.67
Upside: +858.08%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.56
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.00
Upside: +788.89%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.44
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.28
Upside: +777.19%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.37
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.08
Upside: +292.16%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.10
Upside: +309.84%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.18
Upside: +577.97%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $11.33
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.76
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $32.04
Upside: +71.66%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $14.75
Upside: +245.76%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $4.34
Upside: +61.29%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $6.08
Upside: +821.05%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $9.57
Upside: +223.93%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $7.15
Upside: +9,690.21%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $24.44
Upside: +22.75%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $0.95
Upside: +1,163.16%